AARON L CLAYSON
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Gerontology CHUBBUCK, ID NPI 1629814892
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Gerontology ID Retrophin, Inc. All categories
General Payments — all program years on this page
$247.41
- Category: General Payments
- Program years: PY2024
- Record count: 8
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $247.41 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $247.41 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Retrophin, Inc. | $77.97 | 2 |
| Medtronic, Inc. | $70.61 | 1 |
| Novo Nordisk AS | $35.00 | 1 |
| Ardelyx, Inc. | $26.73 | 2 |
| Otsuka America Pharmaceutical, Inc. | $23.11 | 1 |
| CALLIDITAS THERAPEUTICS US INC. | $13.99 | 1 |
By program year
| Program year | Amount | Records |
|---|---|---|
| 2024 | $247.41 | 8 |
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1100576512 | Novo Nordisk Inc | $35.00 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1116971259 | Medtronic, Inc. | $70.61 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1119046112 | Otsuka America Pharmaceutical, Inc. | $23.11 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1141524230 | CALLIDITAS THERAPEUTICS US INC. | $13.99 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1146722208 | Ardelyx, Inc. | $13.62 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1146722210 | Ardelyx, Inc. | $13.11 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1149914950 | Travere Therapeutics, Inc. | $14.63 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1149914954 | Travere Therapeutics, Inc. | $63.34 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.